U.S. appeals court ruling may clear barrier to generic OxyContin
February 01, 2016 at 15:38 PM EST
Feb 1 (Reuters) - A federal appeals court ruled Monday that four patents related to Purdue Pharma's painkiller OxyContin are invalid, potentially bringing Teva Pharmaceutical Industries Ltd and others a step closer to introducing generic versions of the drug.
